Pharmaceuticals

Contraceptives Market Forecast: What to Expect by 2029

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Contraceptives Market Between 2025 And 2029?

The contraceptives market has experienced robust expansion over recent years. Projections indicate its value will rise from $27.92 billion in 2024 to $29.74 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 6.5%. This historical expansion is primarily due to factors such as the advent of the birth control pill, heightened awareness and educational efforts regarding contraception, legislative and societal shifts advocating for reproductive rights, worldwide population management programs, and the rising adoption of generic and affordable drugs and devices.

The contraceptives market is anticipated to show robust expansion over the next few years, with its valuation expected to reach $40 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.7%. This projected increase is fueled by factors such as an intensified focus on male contraceptives, improved access to birth control in emerging economies, the integration of digital health technologies within contraception, a rising demand for long-acting reversible contraceptives (LARCS), and enhanced availability of over-the-counter drugs through online platforms. Significant trends foreseen in this forecast period encompass technological progress in contraceptive approaches, a move towards non-hormonal and natural methods, the broadening of over-the-counter access for specific contraceptives, a prioritization of user-friendly and discreet options, and the incorporation of telemedicine into contraceptive counseling and prescription services.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6920&type=smp

Which Drivers Are Impacting The Contraceptives Market?

The increasing incidence of sexually transmitted diseases (STDs) is fueling the need for contraceptives. STDs refer to infections transmitted between individuals via sexual contact. While most commonly spread through anal, oral, and vaginal intercourse, they can also be transmitted via other forms of close physical contact. Contraceptives are utilized to help control the spread of STDs such as herpes and HPV, which often transmit through skin-to-skin contact. For example, in May 2023, data from the Minnesota Department of Health, a US-based state health agency, revealed that primary and secondary syphilis cases rose by 19% in 2022, increasing from 564 in 2021 to 676 in 2022. Furthermore, 20 instances of congenital syphilis in infants were reported in 2022. This marked a 42% increase from the 14 cases of congenital syphilis documented in 2021. Consequently, the growing prevalence of sexually transmitted diseases is projected to escalate the demand for contraceptives throughout the forecast period.

How Is The Contraceptives Market Classified Into Different Segments?

The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices

2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years

3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Subsegments:

1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills

2) By Topical Contraceptives: Transdermal Patches, Gel Applications

3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables

4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms

5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings

6) By Condoms: Male Condoms, Female Condoms

7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges

8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants

9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs

Which Ongoing Trends Are Expected To Shape The Contraceptives Market Outlook?

Leading companies in the contraceptives market are concentrating on developing innovative birth control methods, such as the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptives, to improve user convenience, boost effectiveness, and offer long-term birth control solutions. These advancements aim to decrease the need for frequent dosing, enhance accessibility, and minimize side effects, thereby providing more dependable and discreet contraceptive options for individuals seeking better reproductive health management. For instance, in October 2023, the Health and Family Welfare Ministry, an India-based government agency, introduced two new methods, the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive, intended to enhance family planning services. These methods are integrated into the National Family Planning Programme and are designed to improve maternal and infant health outcomes. The introduction of these contraceptives seeks to reduce maternal and infant morbidity and mortality rates by expanding family planning choices. This initiative reflects a broader strategy to upgrade reproductive health services in Karnataka, ensuring that women have access to safe and effective contraceptive methods.

Who Are The Core Companies Influencing The Contraceptives Market Landscape?

Major companies operating in the contraceptives market include Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Medisafe Distribution Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

What Are The Key Regional Factors Influencing The Contraceptives Market Growth?

North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Contraceptives Market Report:

https://www.thebusinessresearchcompany.com/customise?id=6920&type=smp

Browse Through More Reports Similar to the Global Contraceptives Market 2025, By The Business Research Company

Hormonal Contraceptives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Polycystic Ovarian Syndrome Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

Genito Urinary Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795